We recently identified the oncofetal RBP Insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) as an important regulator of gene expression in MLL-rearranged B-ALL [22]. The gene discussed is KMT2A; the disease is precursor B-cell acute lymphoblastic leukemia.